Report Detail
Global Zika Virus Market Insights, Forecast to 2025
- RnM2931130 |
- 12 February, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Zika virus disease (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections.
Zika virus disease (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. Based on research to date, there is scientific consensus that Zika virus is a cause of microcephaly and GBS.
Zika virus is primarily transmitted to people through the bite of an infected mosquito from the Aedes genus, mainly Aedes aegypti in tropical regions. Sexual transmission of Zika virus is also possible. Other modes of transmission such as blood transfusion are being investigated.
Zika virus is a mosquito-borne flavivirus that was first identified in Uganda in 1947 in monkeys through a network that monitored yellow fever. It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania. Outbreaks of Zika virus disease have been recorded in Africa, the Americas, Asia and the Pacific. From the 1960s to 1980s, human infections were found across Africa and Asia, typically accompanied by mild illness. The first large outbreak of disease caused by Zika infection was reported from the Island of Yap (Federated States of Micronesia) in 2007. In July 2015 Brazil reported an association between Zika virus infection and Guillain-Barré syndrome. In October 2015 Brazil reported an association between Zika virus infection and microcephaly.
The global Zika Virus market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Zika Virus market based on company, product type, end user and key regions.
This report studies the global market size of Zika Virus in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Zika Virus in these regions.
This research report categorizes the global Zika Virus market by top players/brands, region, type and end user. This report also studies the global Zika Virus market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Market size by Product
Sexual Transmission
Blood Transfusion
Market size by End User
Hospitals
Clinics
Ambulatory Surgery Centers
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Zika Virus market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Zika Virus market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Zika Virus companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Zika Virus submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Zika Virus are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Zika Virus market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Zika Virus Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Zika Virus Market Size Growth Rate by Product
- 1.4.2 Sexual Transmission
- 1.4.3 Blood Transfusion
- 1.5 Market by End User
- 1.5.1 Global Zika Virus Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Ambulatory Surgery Centers
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Zika Virus Market Size
- 2.1.1 Global Zika Virus Revenue 2014-2025
- 2.1.2 Global Zika Virus Sales 2014-2025
- 2.2 Zika Virus Growth Rate by Regions
- 2.2.1 Global Zika Virus Sales by Regions
- 2.2.2 Global Zika Virus Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Zika Virus Sales by Manufacturers
- 3.1.1 Zika Virus Sales by Manufacturers
- 3.1.2 Zika Virus Sales Market Share by Manufacturers
- 3.1.3 Global Zika Virus Market Concentration Ratio (CR5 and HHI)
- 3.2 Zika Virus Revenue by Manufacturers
- 3.2.1 Zika Virus Revenue by Manufacturers (2014-2019)
- 3.2.2 Zika Virus Revenue Share by Manufacturers (2014-2019)
- 3.3 Zika Virus Price by Manufacturers
- 3.4 Zika Virus Manufacturing Base Distribution, Product Types
- 3.4.1 Zika Virus Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Zika Virus Product Type
- 3.4.3 Date of International Manufacturers Enter into Zika Virus Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Zika Virus Sales by Product
- 4.2 Global Zika Virus Revenue by Product
- 4.3 Zika Virus Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Zika Virus Breakdown Data by End User
6 North America
- 6.1 North America Zika Virus by Countries
- 6.1.1 North America Zika Virus Sales by Countries
- 6.1.2 North America Zika Virus Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Zika Virus by Product
- 6.3 North America Zika Virus by End User
7 Europe
- 7.1 Europe Zika Virus by Countries
- 7.1.1 Europe Zika Virus Sales by Countries
- 7.1.2 Europe Zika Virus Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Zika Virus by Product
- 7.3 Europe Zika Virus by End User
8 Asia Pacific
- 8.1 Asia Pacific Zika Virus by Countries
- 8.1.1 Asia Pacific Zika Virus Sales by Countries
- 8.1.2 Asia Pacific Zika Virus Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Zika Virus by Product
- 8.3 Asia Pacific Zika Virus by End User
9 Central & South America
- 9.1 Central & South America Zika Virus by Countries
- 9.1.1 Central & South America Zika Virus Sales by Countries
- 9.1.2 Central & South America Zika Virus Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Zika Virus by Product
- 9.3 Central & South America Zika Virus by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Zika Virus by Countries
- 10.1.1 Middle East and Africa Zika Virus Sales by Countries
- 10.1.2 Middle East and Africa Zika Virus Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Zika Virus by Product
- 10.3 Middle East and Africa Zika Virus by End User
11 Company Profiles
- 11.1 Bharat Biotech
- 11.1.1 Bharat Biotech Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bharat Biotech Zika Virus Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bharat Biotech Zika Virus Products Offered
- 11.1.5 Bharat Biotech Recent Development
- 11.2 Inovio Pharmaceuticals and GeneOne Life Sciences
- 11.2.1 Inovio Pharmaceuticals and GeneOne Life Sciences Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Products Offered
- 11.2.5 Inovio Pharmaceuticals and GeneOne Life Sciences Recent Development
- 11.3 Intrexon
- 11.3.1 Intrexon Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Intrexon Zika Virus Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Intrexon Zika Virus Products Offered
- 11.3.5 Intrexon Recent Development
- 11.4 Cerus
- 11.4.1 Cerus Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Cerus Zika Virus Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Cerus Zika Virus Products Offered
- 11.4.5 Cerus Recent Development
- 11.5 Sanofi
- 11.5.1 Sanofi Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sanofi Zika Virus Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sanofi Zika Virus Products Offered
- 11.5.5 Sanofi Recent Development
- 11.6 NewLink Genetics
- 11.6.1 NewLink Genetics Company Details
- 11.6.2 Company Business Overview
- 11.6.3 NewLink Genetics Zika Virus Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 NewLink Genetics Zika Virus Products Offered
- 11.6.5 NewLink Genetics Recent Development
- 11.7 Immunovaccine
- 11.7.1 Immunovaccine Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Immunovaccine Zika Virus Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Immunovaccine Zika Virus Products Offered
- 11.7.5 Immunovaccine Recent Development
- 11.8 GlaxoSmithKline
- 11.8.1 GlaxoSmithKline Company Details
- 11.8.2 Company Business Overview
- 11.8.3 GlaxoSmithKline Zika Virus Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 GlaxoSmithKline Zika Virus Products Offered
- 11.8.5 GlaxoSmithKline Recent Development
12 Future Forecast
- 12.1 Zika Virus Market Forecast by Regions
- 12.1.1 Global Zika Virus Sales Forecast by Regions 2019-2025
- 12.1.2 Global Zika Virus Revenue Forecast by Regions 2019-2025
- 12.2 Zika Virus Market Forecast by Product
- 12.2.1 Global Zika Virus Sales Forecast by Product 2019-2025
- 12.2.2 Global Zika Virus Revenue Forecast by Product 2019-2025
- 12.3 Zika Virus Market Forecast by End User
- 12.4 North America Zika Virus Forecast
- 12.5 Europe Zika Virus Forecast
- 12.6 Asia Pacific Zika Virus Forecast
- 12.7 Central & South America Zika Virus Forecast
- 12.8 Middle East and Africa Zika Virus Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Zika Virus Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Zika Virus . Industry analysis & Market Report on Zika Virus is a syndicated market report, published as Global Zika Virus Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Zika Virus market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
